{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-046414","form_type":"8-K","ticker":"BFRI","cik":"0001858685","company_name":"Biofrontera Inc.","filed_at":"2023-12-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.148058+00:00","generated_at":"2026-06-07T06:31:29.283433+00:00","sec_items":["1.01","1.02","2.03"],"event_type":"debt","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Biofrontera enters $4M secured loan agreements maturing July 2024","bullets":["Two term loans of $2M each from Lender A and B, evidenced by secured promissory notes dated Dec 21, 2023.","Weekly principal and interest payments of ~$102,857 per loan; total interest per loan ~$880,000.","Maturity July 5, 2024; loans secured by substantially all company assets with customary covenants.","Company voluntarily terminating $6.5M MidCap Business Credit line of credit in connection with the new loans."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-046414","json":"https://secwatch.observer/filing/0001493152-23-046414.json","markdown":"https://secwatch.observer/filing/0001493152-23-046414.md","text":"https://secwatch.observer/filing/0001493152-23-046414.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223046414/0001493152-23-046414-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223046414/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T06:31:29.283433+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3da6e2ab80a8c5e6288aa54651cd0d2debd03f84","claim":"Biofrontera Inc. incurred term loan of $2,000,000 with Lender A maturing July 5, 2024.","evidence_excerpt":"On December 21, 2023, Biofrontera, Inc. (the \"Company\") entered into (a) a Business Loan and Security Agreement (the \"Agreement A\") pursuant to which the lender (\"Lender A\") has made a term loan to the Company in the principal amount of $2,000,000 (\"Loan A\"), evidenced by a Secured Promissory Note, effective as of December 21, 2023 (\"Note A\"), made by the Company in favor of Lender A","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223046414/0001493152-23-046414-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"$2,000,000"},{"label":"Counterparty","value":"Lender A"},{"label":"Maturity","value":"July 5, 2024"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"f1f19e9ba43e57f6e376d54793d7922a4ab1ebeb","claim":"Biofrontera Inc. incurred term loan of $2,000,000 with Lender B maturing July 5, 2024.","evidence_excerpt":"and (b) a Business Loan and Security Agreement (\"Agreement B\" and together with the Agreement A, the \"Loan Agreements\") pursuant to which the lender (\"Lender B\") has made a term loan to the Company in the principal amount of $2,000,000 (the \"Loan B\" and together with the Loan A, the \"Loans\"), evidenced by a Secured Promissory Note, effective as of December 21, 2023 (\"Note B\"), made by the Company in favor of Lender B.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223046414/0001493152-23-046414-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"$2,000,000"},{"label":"Counterparty","value":"Lender B"},{"label":"Maturity","value":"July 5, 2024"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"56b63632a23b66710c7a9f849e9eb8c73ee8b2cb","claim":"Biofrontera Inc. entered into Business Loan and Security Agreements A and B with Lender A and Lender B valued at Two term loans of $2,000,000 each, total $4,000,000 (effective 2023-12-21).","evidence_excerpt":"On December 21, 2023, Biofrontera, Inc. (the “Company”) entered into (a) a Business Loan and Security Agreement (the “Agreement A”) pursuant to which the lender (“Lender A”) has made a term loan to the Company in the principal amount of $2,000,000 (“Loan A”), evidenced by a Secured Promissory Note, effective as of December 21, 2023 (“Note A”), made by the Company in favor of Lender A; and (b) a Business Loan and Security Agreement (“Agreement B” and together with the Agreement A, the “Loan Agreements”) pursuant to which the lender (“Lender B”) has made a term loan to the Company in the principal amount of $2,000,000 (the “Loan B” and together with the Loan A, the “Loans”), evidenced by a Secured Promissory Note, effective as of December 21, 2023 (“Note B”), made by the Company in favor of Lender B.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223046414/0001493152-23-046414-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Lender A and Lender B"},{"label":"Value","value":"Two term loans of $2,000,000 each, total $4,000,000"},{"label":"Effective","value":"2023-12-21"}],"fact_type":"material_agreement"},{"claim_id":"a458d51a082d8f325a6731c86ef5b98acb8fe3b9","claim":"Biofrontera Inc. terminated Revolving line of credit with MidCap Business Credit LLC with MidCap Business Credit LLC valued at Voluntary termination of revolving line of credit that provided for maximum borrowings of $6.5 milli.","evidence_excerpt":"In connection with entering into the Agreement A and Agreement B, the Company is in the process of voluntarily terminating the revolving line of credit between the Company and MidCap Business Credit LLC that provided for maximum borrowings of $6.5 million, subject to a borrowing base and an availability block.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223046414/0001493152-23-046414-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"MidCap Business Credit LLC"},{"label":"Value","value":"Voluntary termination of revolving line of credit that provided for maximum borrowings of $6.5 milli"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}